Immunotherapies for cancer — treatments that prime the immune system to attack tumors — are valuable weapons in the anti-cancer arsenal. But some cancers are more difficult to target with this strategy than others. Today, scientists report a new type of immunotherapy that dramatically extends the survival of mice that have triple negative breast tumors, a difficult-to-treat form of cancer.
Subscribe! [ Ссылка ]
Facebook! [ Ссылка ]...
Twitter! [ Ссылка ]
You might also like:
Headline Science:
[ Ссылка ]...
Speaking of Chemistry:
[ Ссылка ]...
Produced by the American Chemical Society, the world’s largest scientific society. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences.
Join the American Chemical Society! [ Ссылка ]
